---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-25-090201"
form_type: "8-K"
ticker: "TCRT"
cik: "0001107421"
company_name: "Alaunos Therapeutics, Inc."
filed_at: "2025-06-26T23:59:59+00:00"
generated_at: "2026-05-18T17:22:49.988191+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Alaunos Therapeutics raises $850K via private placement of Series A-2 Convertible Preferred Stock

## Summary
- Aggregate purchase price of $850,000 from accredited investors; offering closed June 24, 2025.
- Each Series A-2 Preferred share priced at $1,000, convertible into common at $4.49 per share.
- Preferred stock carries 10% annual dividend payable in additional Preferred shares.
- Shares issued under Section 4(a)(2) and/or Rule 506(b), are restricted and not registered under Securities Act.
- 1,000 Series A-2 shares designated; 1,639,521 common shares outstanding prior to the offering.

## SEC filing metadata
- accession: 0000950170-25-090201
- form_type: 8-K
- ticker: TCRT
- cik: 0001107421
- company_name: Alaunos Therapeutics, Inc.
- filed_at: 2025-06-26T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 3.02, 3.03, 5.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1107421/000095017025090201/0000950170-25-090201-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1107421/000095017025090201/tcrt-20250624.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-25-090201
- JSON: https://secwatch.observer/filing/0000950170-25-090201.json
- Plain text: https://secwatch.observer/filing/0000950170-25-090201.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.